ASPIVIX SA
PrivateLast Round
Crowdfunding
Jun 26, 2026
Est. Valuation
$24.05M
Total Funding Raised
$12.64M
Company Overview
ASPIVIX SA operates in Healthcare & Life Sciences and is based in Epalinges. Its latest recorded funding round was a Series B Extension round in March 2025.
ASPIVIX SA is a medical device company that develops innovative, suction-based cervical stabilizers designed to modernize gynecological procedures and improve patient comfort.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ASPIVIX SA Comparables
Compare ASPIVIX SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioceptive | 90% | |
| The Cooper Companies | 73% | |
| MedGyn Products | 70% |
For institutional investors. Book with your work email.
ASPIVIX SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jun 26, 2026 | ||||
| Series B Extension | Mar 14, 2025 | ||||
| Series A Extension | Nov 17, 2022 | ||||
| Grant | Nov 17, 2022 | ||||
| Grant | Jun 1, 2019 | ||||
Series A | Aug 20, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ASPIVIX SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eurostars SME programme | Grant |
| Business Angels Switzerland | Series A |
| 4FOX Ventures | Series A Extension, Series A |
| Innosuisse | Grant |
| Venture Kick | Grant |
| Capital Cell | Crowdfunding, Series B Extension |
| Zurcher Kantonalbank | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
Monthly visitors increased 44% MoM, reaching 12.2K.
- Nov 15, 2025
Grew 29% QoQ, from 17 to 22 employees.
For institutional investors. Book with your work email.
ASPIVIX SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ASPIVIX SA's valuation, stock price, and market status.
Is ASPIVIX SA a public or private company?
ASPIVIX SA is a private company.
What is the current stock price of ASPIVIX SA?
ASPIVIX SA is a private company, so its shares have no public market price. Caplight tracks ASPIVIX SA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ASPIVIX SA worth (valuation)?
ASPIVIX SA's valuation is estimated at $24.1M based on funding round data.
Can I buy ASPIVIX SA stock?
ASPIVIX SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ASPIVIX SA's last funding round?
ASPIVIX SA's most recent funding round was Crowdfunding on June 26, 2026.
Who are the main investors in ASPIVIX SA?
Key investors in ASPIVIX SA include 4FOX Ventures.
Will ASPIVIX SA IPO soon?
No public IPO plans have been announced for ASPIVIX SA.
How can I track ASPIVIX SA secondary market activity?
Caplight tracks bids, offers, and trades in ASPIVIX SA's shares on secondary markets.